US approves second gene therapy against cancer

October 19, 2017 in International

US regulators have approved a second form of gene therapy to fight cancer. The treatment, called Yescarta, is the first immunotherapy on the US market for certain kinds of non-Hodgkin lymphoma (NHL), a cancer that attacks the lymph nodes. Known as a chimeric antigen receptor (CAR)...